Winpro Pharma Process Technologies Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 25-12-2024
- Paid Up Capital ₹ 0.92 M
as on 25-12-2024
- Company Age 16 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 0.18 M
as on 25-12-2024
- Revenue %
(FY 2020)
- Profit -28.25%
(FY 2020)
- Ebitda 8.43%
(FY 2020)
- Net Worth -1.04%
(FY 2020)
- Total Assets -0.28%
(FY 2020)
About Winpro Pharma Process Technologies
The Company is engaged in the Machinery And Equipment Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.92 M.
The company currently has active open charges totaling ₹0.18 M.
Kishor Bhojak and Kaushika Bhojak serve as directors at the Company.
- CIN/LLPIN
U24239MH2008PTC185652
- Company No.
185652
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Aug 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Winpro Pharma Process Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kishor Bhojak  | Director | 15-May-2021 | Current |
| Kaushika Bhojak | Director | 08-Aug-2008 | Current |
Financial Performance of Winpro Pharma Process Technologies.
Winpro Pharma Process Technologies Private Limited, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 28.25% decrease in profit. The company's net worth dipped by a decrease of 1.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Winpro Pharma Process Technologies?
In 2019, Winpro Pharma Process Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Wintech Pharmachem Equipments Private LimitedActive 22 years 11 monthsKishor Bhojak and Kaushika Bhojak are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Oriental Bank Of Commerce Creation Date: 31 Oct 2012 | ₹0.18 M | Open |
How Many Employees Work at Winpro Pharma Process Technologies?
Unlock and access historical data on people associated with Winpro Pharma Process Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winpro Pharma Process Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winpro Pharma Process Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
